Stocks pushing your portfolio higher next quarter

As Tuesday marked the close of this year's first quarter, Jim Cramer was less than impressed with what he saw this year. He suspects there is one problem that is in the back of investors' minds with every decision they make—and it has now become a big deal.

"Let me say just from the get-go that this market's leaving a sour taste in my mouth. The vast majority of stocks out there just churn. After years where stocks were constantly breaking out to new heights, many stocks now seem trapped," said the "Mad Money" host.

So what changed since the beginning of the year that caused the market to lose its mojo?

To Cramer, the answer is simple. Investors are trapped in an economy that has downshifted, and while the Federal Reserve seems to want to make aggressive decisions—it cannot. The data indicates that it's not worth raising interest rates right now, but then it also shows that the economy is too strong and a raise in interest rates should at least be thought about.

This conundrum is feeding into every investment decision right now. Cramer thinks this explains why the healthcare group is so strong, because that is what you buy when things slow down and you are worried that companies can't beat earnings estimates. Healthcare will perform regardless of what's going on in the world.

First up for the winners, were stocks that were takeovers; Hospira, being bought by Pfizer, and Kraft which was gobbled up by Heinz. Cramer thinks these were smart acquisitions, as both companies needed to show growth.

What do the winners have in common? Ultimately the choppy first quarter showed that this year will favor those companies that don't rely on economic strength to grow, or rely on increased consumer spending thanks to cheaper gasoline prices.

Read MoreCramer: Problem feeding all investing decisions now

Jim Cramer Mad Money
Source: CNBC

One place that Cramer thinks the big boys will be placing their bets in the second quarter; will be the big liquid growth stocks like Heinz-Kraft, or drug company Actavis.

And while Actavis has been on fire ever since it acquired Forest Labs and Allergan, Cramer still thinks it has legs to run well into the second quarter.

Actavis CEO Brent Saunders has now created what he calls a "leader in a new industry model, 'growth pharma.'" Considering that big pharma has been filled up with nothing but slow growing monsters like Pfizer, Eli Lilly, AstraZeneca and GlaxoSmithKline; Cramer thinks this is a big move.

Thus, the "Mad Money" host thinks that portfolio managers everywhere will be scooping up companies like Actavis and Heinz-Kraft that offer so much growth.

It also looks like beloved cult stock fan fave Tesla could have some serious competition on its hands. Thus far it has been basically competition free when it comes to selling electric cars. However, Volkswagen subsidiary Audi revealed a whole lineup of electrified cars at the New York Auto Show this week.

In fact, Cramer anticipates that Audi could become Tesla's main competitor in the next two years. It already sells a plug-in hybrid and the A3 e-tron in Europe, and next month it will be coming to the United States.

Could Audi be a Tesla killer? To find out Cramer sat down with the President of Audi in America, Scott Keogh.

"You have to look at the reality of it on the ground. The infrastructure is not quite there, and what customers want is they want 100 percent peace of mind. If they can get the car charged, they can handle it," Keogh said.

One day the S&P 500 is up, the next day it's down. What a roller coaster ride! Cramer has had enough of the volatility, and thought this would be a good time to circle back to one of "Mad Money's" guru technicians to find out what could be in store for investors ahead.

That is why Cramer went off the charts and spoke with Carolyn Boroden, a technician who runs and is one of Cramer's colleagues at

Approximately one year ago, Cramer spoke with Boroden about where the S&P could be headed. At the time the index was trading at 1,885, and Boroden said she could see the S&P ultimately make its way up to 2,138. Back then, Cramer thought this was an aggressive call. Fast forward to today, and the S&P is about 50 points away. Wowzer!

Now that we have almost reached her outrageously bullish target in the S&P, where could it be headed next?

Looking at the charts, Boroden thinks it is time to become cautious. Her main concern is driven by the fact that the chart shows the same pattern in the S&P that she saw recently in the Russell 2000 before it had its nasty breakdown.

So while a correction could be in the cards of the S&P 500, Boroden does not predict it to be a vicious one. However, it is time to approach the market with caution.

"I say, going into an uncertain earnings period, it never hurts to raise a little cash, certainly less cautionary than Boroden, but I'm not taking the other side of the trade, either," Cramer added.

Read More Cramer: S&P 500 charts predict—time to raise cash!

In fact, if things were in Cramer's hands right now the entire internet would be different.

"The natural buyer for every major online service vertical has left the building, and it's time for other companies to step up if they want to be relevant on the web," the "Mad Money" host said.

Just think about it—right now Google runs everything. And most individuals of importance in the restaurant, travel, entertainment and real estate business have figured out that Google is going to either create a service that competes with them, or buy the one that they use.

The good news is that Cramer sees a unique opportunity to cash in on Google's weakness.

Right now, Google is under such tough scrutiny from regulators, that the competition has a chance to make a move and get ahead of the Internet giant before it even makes a move to acquire the competition. Perhaps now is the time for Microsoft or Yahoo to make a move?

Read MoreCramer: Google's weakness presents opportunity

In the Lightning Round, Cramer gave his take on a few caller favorite stocks:

Core Laboratories: "I think that Core Labs has bottomed. I think we've seen the bottom for this cycle, and I know that's a gutsy call. But I think that if it got back to that $90 it would be a gift. I think you put some on here, and let it come down."

Devon Energy Corp: "Too dicey for me. I've got so many that I like more than Devon, I'm not going to pull the trigger on Devon."

Read MoreLightning Round: Too many secondaries, be careful!